Franklin Berger Buys Shares of AVIR

Franklin Berger purchased 29,600 shares of AVIR on June 18, 2026. The transaction did not include a disclosed purchase price or total value. This insider activity comes alongside other notable moves in AVIR's ownership landscape.

Other Institutional Activity in AVIR

FMR LLC increased its holdings in AVIR by 2,271,776 shares, bringing its total to 11,950,772 shares valued at about $64.3 million, a 23.5% increase. BlackRock, Inc. slightly trimmed its position by 55,765 shares, now holding 8,435,437 shares worth approximately $45.4 million, marking a 0.7% decrease. BML Capital Management, LLC reduced its stake by 431,343 shares, leaving it with 7,058,657 shares valued at $37.98 million, a 5.8% decrease. Meanwhile, Vanguard Capital Management LLC opened a new position with 3,246,124 shares valued at $17.46 million, and Bain Capital Life Sciences Investors, LLC cut its holdings by 125,000 shares to 2,360,638 shares, worth about $12.7 million, a 5.0% decrease.

AVIR Stock Snapshot

Shares of AVIR traded near $4.39 on Wednesday. The stock's recent activity reflects a diverse range of institutional interest, with some funds increasing their stakes while others reduced theirs. The stock's performance and institutional adjustments indicate varied sentiment among investors.

Insider Buying and Selling at AVIR

On June 18, 2026, several insiders made transactions involving AVIR shares. Howard Berman purchased 37,700 shares, Bruno Lucidi bought 26,700 shares and sold 29,600 shares, Franklin Berger bought 29,600 shares and also sold 29,600 shares, and Polly Murphy sold 29,600 shares. These transactions were not part of any pre-planned trading programs.

Analysts Set New Price Targets

On March 9, 2026, Evercore ISI Group maintained its 'buy' rating for AVIR with a price target of $10. Morgan Stanley, on April 11, 2025, maintained a 'hold' rating with a $6 target. These ratings reflect a mixed outlook from analysts, with some seeing potential for growth while others remain cautious.

Bottom Line

Franklin Berger's recent purchase adds to a series of insider activities in AVIR. The stock's trading at $4.39 and the varied institutional and analyst perspectives highlight the ongoing interest and differing opinions on its potential. As always, remember that insider transactions are just one piece of the investment puzzle and may not predict future performance.